- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT03194191
Pregnancy With Insomnia: a Trial of Acupuncture (GAS)
Acupuncture is widely used for treatment of insomnia. The research hypothesis is that acupuncture may be more effective than sham acupuncture to treat insomnia during pregnancy.
GAS is a randomized controlled trial with placebo acupuncture using the insomnia severity index (ISI) as the main outcome criterion.
Descripción general del estudio
Descripción detallada
Scientific justification:
- During pregnancy, insomnia occurs mainly in women without a previous history of sleep disorder, and may remain after delivery. Insomnia affects the quality of life. It might be associated with an increase in labor duration and cesarean section rate.
Insomnia tends to worsen during gestation, owing to back pain, an increased need to micturate, and the movement of the fetus. Sleep disorders are often associated with restless legs syndrome.
- To treat insomnia during pregnancy, the Haute Autorité de Santé (HAS) recommends avoiding using psychotropic medications. It also recommends screening for depression or anxiety traits often associated with insomnia. However, in most cases, psychological means alone fail to treat insomnia effectively.
- Based on 11 randomized controlled trials, the odds of improving sleep disorders are 3 times greater with than without acupuncture, but the methodological quality of these trials is considered insufficient to conclude.
Population:
The study focused on pregnant women suffering from insomnia, excluding women with pregnancies complicated by pre-eclampsia, fetal growth anomalies, or threatened premature labor for fear those complications might interact with sleep disorders, as well as women with known psychiatric disorders. We also excluded women with a history of insomnia before pregnancy to focus on insomnia triggered by pregnancy only.
Objectives:
- Primary objective: To assess the effect of a standardized acupuncture protocol vs. placebo on insomnia during pregnancy.
- Secondary objectives: To assess the effect of a standardized acupuncture protocol vs. placebo on (i) the Pittsburgh Sleep Quality Index (PSQI), (ii) anxiety and depression traits, (iii) use of psychotropic medicines and (iv) recreational substances, (v) the incidence of restless legs syndrome, (vi) perinatal outcome .
Study design:
- Study Type: Multicentre, Interventional, randomized, 2 parallel groups
- Endpoint Classification: Efficacy Study
- Intervention Model: Parallel Assignment
- Masking: Single blind (patient blinded to intervention)
- Primary Purpose: Treatment
- One acupuncture session weekly for 4 consecutive weeks
Visits:
- Selection: When a pregnant woman complains from insomnia, the health professional in charge will fill a checklist of inclusion and exclusion criteria, provide the patient with a pre inclusion ISI questionnaire and give the patient an information sheet and a copy of the consent. When a pregnant woman is sent to the acupuncturist for sleep disorders, he or she may proceed to the selection visit.
- Inclusion: The acupuncturist checks for inclusion and exclusion criteria, collects the patient written consent, performs the clinical examination, gives the corresponding self-assessment questionnaires and proceeds to computerized randomization.
- Follow-up: At visits 1 to 4, the acupuncturist performs the treatment, and records side effects if any. Visits are scheduled on a weekly basis.
- End of research: At visit 5 (one week after last acupuncture session), the acupuncturist gives the corresponding self-assessment questionnaires.
Tipo de estudio
Inscripción (Anticipado)
Fase
- No aplica
Contactos y Ubicaciones
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Age > 18 years
- Singleton pregnancy
- Gestational age ≥ 16 weeks + 0 day and ≤ 32 weeks + 6 days
- Insomnia Severity Index ≥ 10
- Insomnia reported to have started during pregnancy and at least 2 weeks before inclusion
- Patient understanding the study
- Informed consent signed
- Social insurance available at inclusion and until the end of pregnancy
Exclusion Criteria:
- Threatened premature labor
- Small fetus for gestational age
- Pre-eclampsia
- Insomnia starting before pregnancy
- Use of psychotropic drugs before pregnancy
- Use of recreational drugs during pregnancy
- Known psychiatric disorder
- Anticoagulant therapy
- Patient reporting insomnia results from chronic or acute pain
- Obstructive sleep apnea (OSA) requiring treatment
- Patient under antidepressant therapy
- Patient under legal guardianship or deprived of freedom
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Regular acupuncture needles
Real acupuncture procedure The real acupuncture will be performed by means of standard stainless-steel needles (0.30-mm diameter, 30-mm length/Gauge 8 x 1.2"), located bilaterally in 5 real acupoints.
|
The patient will be in a semi recumbent position during needle penetration.
Duration of needle insertion: 30 minutes
|
|
Comparador falso: Sham acupuncture needles
Sham acupuncture with a no penetrating sham needle (blunt and telescopic), giving the impression of insertion but without penetrating the skin will be placed bilaterally in 5 false acupoints
|
The patient will be in a semi recumbent position during needle penetration.
Duration of needle insertion: 30 minutes
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Insomnia severity index (ISI)
Periodo de tiempo: Inclusion visit and 5 weeks after the first acupuncture session
|
Difference of ISI self-report questionnaire administrated at inclusion visit and 5 weeks after the first acupuncture session
|
Inclusion visit and 5 weeks after the first acupuncture session
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Pittsburgh Sleep Quality Index (PSQI)
Periodo de tiempo: Inclusion visit and 5 weeks after the first acupuncture session
|
Difference of PSQI self-report questionnaire administrated at inclusion visit and 5 weeks after the first acupuncture session
|
Inclusion visit and 5 weeks after the first acupuncture session
|
|
Hospital Anxiety and Depression Scale (HADS)
Periodo de tiempo: Inclusion visit and 5 weeks after the first acupuncture session
|
Difference of HADS self-report questionnaire administrated at inclusion visit and 5 weeks after the first acupuncture session
|
Inclusion visit and 5 weeks after the first acupuncture session
|
|
Cumulated dose of each psychotropic medicine
Periodo de tiempo: Inclusion visit and 5 weeks after the first acupuncture session
|
During the study period, the patients will note on a logbook the daily use of any drug.
|
Inclusion visit and 5 weeks after the first acupuncture session
|
|
Cumulated dose of alcohol
Periodo de tiempo: Inclusion visit and 5 weeks after the first acupuncture session
|
During the study period, the patients will note on a logbook the daily use of alcohol.
|
Inclusion visit and 5 weeks after the first acupuncture session
|
|
Cumulated dose of tobacco
Periodo de tiempo: Inclusion visit and 5 weeks after the first acupuncture session
|
During the study period, the patients will note on a logbook the daily use of tobacco.
|
Inclusion visit and 5 weeks after the first acupuncture session
|
|
Cumulated dose of cannabis
Periodo de tiempo: Inclusion visit and 5 weeks after the first acupuncture session
|
During the study period, the patients will note on a logbook the daily use of cannabis.
|
Inclusion visit and 5 weeks after the first acupuncture session
|
|
Cumulated dose of other recreational substances or medicine
Periodo de tiempo: Inclusion visit and 5 weeks after the first acupuncture session
|
During the study period, the patients will note on a logbook the daily use of other recreational substances and medicine.
|
Inclusion visit and 5 weeks after the first acupuncture session
|
|
Difference in the frequency of restless leg syndrome
Periodo de tiempo: Inclusion visit and 5 weeks after the first acupuncture session
|
According to the guidelines of the International Restless Legs Syndrome Study Group. The diagnosis of restless leg will rely on the presence of all of the following criteria:
|
Inclusion visit and 5 weeks after the first acupuncture session
|
|
Perinatal outcome - Gestational age at birth
Periodo de tiempo: At birth
|
The gestational age at birth of the newborn will be recorded.
|
At birth
|
|
Perinatal outcome - birth weight
Periodo de tiempo: At birth
|
The weight (in gr) at birth of the newborn will be recorded.
|
At birth
|
|
Perinatal outcome - birth height
Periodo de tiempo: At birth
|
The height (in cm) at birth of the newborn will be recorded.
|
At birth
|
|
Perinatal outcome - sex
Periodo de tiempo: At birth
|
The sex of the newborn will be recorded.
|
At birth
|
|
Perinatal outcome - perinatal mortality
Periodo de tiempo: At birth
|
The perinatal mortality will be recorded.
|
At birth
|
|
Perinatal outcome - five minutes Apgar score
Periodo de tiempo: At birth
|
The five minutes Apgar score will be recorded.
|
At birth
|
|
Perinatal outcome - cesarean section rate
Periodo de tiempo: At birth.
|
Cesarean section rate will be recorded.
|
At birth.
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Stéphanie Nicolian, Midewife, Assistance Publique - Hôpitaux de Paris
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Anticipado)
Finalización primaria (Anticipado)
Finalización del estudio (Anticipado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- P150951
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
producto fabricado y exportado desde los EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .